DK542089A - Opbevaringsstabilt lyofikseret mdm-praeparat og fremgangsmaade til fremstilling deraf - Google Patents

Opbevaringsstabilt lyofikseret mdm-praeparat og fremgangsmaade til fremstilling deraf

Info

Publication number
DK542089A
DK542089A DK542089A DK542089A DK542089A DK 542089 A DK542089 A DK 542089A DK 542089 A DK542089 A DK 542089A DK 542089 A DK542089 A DK 542089A DK 542089 A DK542089 A DK 542089A
Authority
DK
Denmark
Prior art keywords
solution
acid
benzylpenicilloic
mdm
benzylpenilloic
Prior art date
Application number
DK542089A
Other languages
English (en)
Other versions
DK542089D0 (da
Inventor
Sudhakar S Wagle
Brian D Wilger
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of DK542089D0 publication Critical patent/DK542089D0/da
Publication of DK542089A publication Critical patent/DK542089A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9446—Antibacterials

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
DK542089A 1988-11-01 1989-10-31 Opbevaringsstabilt lyofikseret mdm-praeparat og fremgangsmaade til fremstilling deraf DK542089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26574988A 1988-11-01 1988-11-01

Publications (2)

Publication Number Publication Date
DK542089D0 DK542089D0 (da) 1989-10-31
DK542089A true DK542089A (da) 1990-05-02

Family

ID=23011751

Family Applications (1)

Application Number Title Priority Date Filing Date
DK542089A DK542089A (da) 1988-11-01 1989-10-31 Opbevaringsstabilt lyofikseret mdm-praeparat og fremgangsmaade til fremstilling deraf

Country Status (7)

Country Link
EP (1) EP0367090B1 (da)
AT (1) ATE100210T1 (da)
DE (1) DE68912270T2 (da)
DK (1) DK542089A (da)
ES (1) ES2048263T3 (da)
IE (1) IE60788B1 (da)
PT (1) PT92163B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT1588U1 (de) * 1994-04-27 1997-08-25 Mahl Christian Dr Verfahren zur herstellung von testsubstanzen für verfahren mit erfassung elektromagnetischer schwingungen
EP1691820A4 (en) * 2003-11-08 2010-03-03 Prothera Biolog PREPARATION AND COMPOSITION OF INTER ALPHA HEMMER PROTEINS FROM HUMAN PLASMA FOR THERAPEUTIC USE
CN106928346B (zh) 2008-05-28 2021-09-07 普罗瑟拉生物公司 来自血液的间-α抑制物蛋白的制备和组合物
WO2014039987A2 (en) 2012-09-09 2014-03-13 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
EP2945703A4 (en) 2013-01-15 2016-08-31 Teva Pharma ALBU-BCHE FORMULATIONS, PREPARATION THEREOF AND USES THEREOF
MX2015008944A (es) * 2013-01-15 2016-06-21 Teva Pharma Proceso de liofilizacion.
CN106187934A (zh) * 2016-07-08 2016-12-07 上海上药新亚药业有限公司 一种羧苄西林钠杂质g的合成方法
CN109789193A (zh) 2016-09-13 2019-05-21 普罗瑟拉生物公司 使用间α抑制蛋白治疗肺病的方法
EP3615937B1 (en) 2017-04-25 2026-01-28 Prothera Biologics, Inc. Methods for quantifying inter-alpha inhibitor proteins
US20180326095A1 (en) * 2017-05-11 2018-11-15 AllerQuest LLC Kits and methods to detect penicillin allergy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183910A (en) * 1978-04-20 1980-01-15 Levine Bernard B Method for testing to predict and/or diagnose allergy to penicillins, and compounds and compositions for use in such tests
US4316882A (en) * 1978-04-20 1982-02-23 Levine Bernard B Compositions for testing to predict and/or diagnose allergy to penicillins
JPS63174927A (ja) * 1987-01-14 1988-07-19 Tanabe Seiyaku Co Ltd 抗菌性凍結乾燥製剤

Also Published As

Publication number Publication date
EP0367090B1 (en) 1994-01-12
ATE100210T1 (de) 1994-01-15
PT92163B (pt) 1995-07-18
EP0367090A1 (en) 1990-05-09
IE60788B1 (en) 1994-08-10
PT92163A (pt) 1990-05-31
DE68912270T2 (de) 1994-04-28
IE893397L (en) 1990-05-01
DK542089D0 (da) 1989-10-31
DE68912270D1 (de) 1994-02-24
ES2048263T3 (es) 1994-03-16

Similar Documents

Publication Publication Date Title
EP0618807B1 (en) A stabilized pharmaceutical formulation comprising growth hormone and histidine
US5849700A (en) Pharmaceutical formulation
US5849704A (en) Pharmaceutical formulation
Needham A quantitative study of succinic acid in muscle: glutamic and aspartic acids as precursors
EP0540582B1 (en) Growth hormone crystals and a process for production of these gh-crystals
US3758683A (en) Insulin product
DK542089D0 (da) Opbevaringsstabilt lyofikseret mdm-praeparat og fremgangsmaade til fremstilling deraf
KR880013572A (ko) 인슐린 및 인슐린 유도체의 혼합결정체, 이의 제조방법, 이를 함유하는 약제 및 이의 용도
IL48122A (en) Injectable pharmaceutical compositions containing a penicillin derivative and container or syringe therefor
CA1285485C (en) Nicorandil-containing preparation for injection
ATE25807T1 (de) Kochsalzersatz-zusammensetzung.
FI881040A0 (fi) Foerfarande foer framstaellning av kristallisk cefadroxil-monohydrat.
US5780599A (en) Growth hormone crystals and a process for production of growth hormone crystals
DK148282B (da) Fremgangsmaade til fremstilling af alkalimetalinsulin
EP0207436A3 (en) New cytidine-diphosphocholine salts, particularly suitable for oral use
RU2080857C1 (ru) Способ получения инъекционной формы препарата хондроитинсульфата "хондролон"
EP0682522B1 (en) Process to prepare pharmaceutical compositions containing vecuronium bromide
US4235900A (en) Cephradine compositions
KR880000691B1 (ko) 세팔렉신의 수용성 유도체의 제조 방법
SU959786A1 (ru) Способ консервировани цельной крови
US4130558A (en) Process for preparation of alkali metal salts of ampicillin
Weil-Malherbe On the synthesis of cocarboxylase
CA1308358C (en) Antibacterial lyophilized preparation
RU2080856C1 (ru) Способ получения инъекционной формы препарата атф
DK167319B1 (da) Stabilt hydrat af et penicillinderivat og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment